These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2886214)

  • 1. Histamine and growth: interaction of antiestrogen binding site ligands with a novel histamine site that may be associated with calcium channels.
    Brandes LJ; Bogdanovic RP; Cawker MD; LaBella FS
    Cancer Res; 1987 Aug; 47(15):4025-31. PubMed ID: 2886214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the antiproliferative action of diphenylmethane-derivative antiestrogen binding site ligands with antagonism of histamine binding but not of protein kinase C-mediated phosphorylation.
    Brandes LJ; Gerrard JM; Bogdanovic RP; Lint DW; Reid RE; LaBella FS
    Cancer Res; 1988 Jul; 48(14):3954-8. PubMed ID: 3164253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the antiestrogen binding site is a histamine or histamine-like receptor.
    Brandes LJ; Macdonald LM; Bogdanovic RP
    Biochem Biophys Res Commun; 1985 Jan; 126(2):905-10. PubMed ID: 2858205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA; Lippman ME; Katzenellenbogen BS
    Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiproliferative potency of histamine antagonists correlates with inhibition of binding of [3H]-histamine to novel intracellular receptors (HIC) in microsomal and nuclear fractions of rat liver.
    Brandes LJ; Davie JR; Paraskevas F; Sukhu B; Bogdanovic RP; LaBella FS
    Agents Actions Suppl; 1991; 33():325-42. PubMed ID: 2053513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New evidence that the antiestrogen binding site may be a novel growth-promoting histamine receptor (?H3) which mediates the antiestrogenic and antiproliferative effects of tamoxifen.
    Brandes LJ; Bogdanovic RP
    Biochem Biophys Res Commun; 1986 Jan; 134(2):601-8. PubMed ID: 3947341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
    Watts CK; Sutherland RL
    Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H3) distinct from the calmodulin-binding site.
    Brandes LJ; Bogdanovic RP; Cawker MD; Bose R
    Cancer Chemother Pharmacol; 1986; 18(1):21-3. PubMed ID: 3757154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand.
    Brandes LJ; Hogg GR
    J Reprod Fertil; 1990 May; 89(1):59-67. PubMed ID: 2374133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diphenylmethane derivative specific for the antiestrogen binding site found in rat liver microsomes.
    Brandes LJ; Hermonat MW
    Biochem Biophys Res Commun; 1984 Sep; 123(2):724-8. PubMed ID: 6548377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
    Hofmann HP; Raschack M; Unger L
    Arzneimittelforschung; 1989 Mar; 39(3):304-8. PubMed ID: 2757655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sites.
    Jones JA; Albright KD; Christen RD; Howell SB; McClay EF
    Cancer Res; 1997 Jul; 57(13):2657-60. PubMed ID: 9205073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiulcerogenic and antisecretory effects of a novel diphenylmethane derivative and antiestrogen binding site ligand.
    Glavin GB; Brandes LJ
    Can J Physiol Pharmacol; 1988 Sep; 66(9):1139-43. PubMed ID: 2905933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogen inhibition of prolactin-induced growth of the Nb2 rat lymphoma cell line.
    Biswas R; Vonderhaar BK
    Cancer Res; 1989 Nov; 49(22):6295-9. PubMed ID: 2804977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonists.
    Brandes LJ; LaBella FS; Warrington RC
    J Natl Cancer Inst; 1991 Sep; 83(18):1329-36. PubMed ID: 1886159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
    Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
    J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells.
    Xu FY; Queen G; Brandes L; Hatch GM
    Proc West Pharmacol Soc; 2007; 50():61-3. PubMed ID: 18605231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
    Sharif NA; Wiernas TK; Griffin BW; Davis TL
    Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.